Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

NCT06162013 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT06162013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06162013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism
Lead sponsor
Haukeland University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
March 5, 2024
Completion date
December 31, 2028
Enrollment
330 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

corticobasal syndrome, multiple system atrophy, progressive supranuclear palsy